Saturday, August 9, 2025

Eguana Tech Files $150.0 Million Base Shelf Prospectus

Eguana Technologies (TSXV: EGT) appears to be prepping for the future. The company last night filed a preliminary short form base shelf prospectus with Canadian regulators, enabling the company to raise funds at a future date.

The base shelf prospectus, which is valid for a period of twenty five months as of yesterday, enables the company to raise up to $150.0 million. Options for raising money include common shares, preferred shares, debt securities, subscription receipts, units, warrants, and share purchase contracts.

At this time, no final short form prospectus has been filed, meaning that the company has not yet signaled that it is raising funds at this moment, but rather has filed the base shelf as a precautionary measure. As such, the use of proceeds currently remains up in the air, with more details to be provided should the company elect to put forth a prospectus supplement with the intention to conduct a transaction.

The filing follows the company having a major announcement in recent weeks, wherein the company has signed a white label agreement with Power Center+, the producer of Duracell Power Center, for premium home energy systems.

Eguana Technologies last traded at $0.465 on the TSX Venture.


FULL DISCLOSURE: Eguana Technologies is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Eguana Technologies on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

New Found Gold: The Queensway PEA

Newmont Q2 Earnings: Setting The Tone For This Earnings Cycle

Highest Grade Antimony Mine in the World!? | James Atkinson – Antimony Resources

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Stifel: “A Lot Continues To Go Right For Eguana”

On March 1st, Eguana Tech (TSXV: EGT) reported its first fiscal quarter of 2022. The...

Saturday, March 5, 2022, 05:10:00 PM

Eguana Tech: $10M Quarter + What’s Coming For 2023 – with Justin Holland

Joining SmallCapSteve to start off the week is Justin Holland, CEO of Eguana Technologies (TSXV:...

Monday, March 13, 2023, 01:30:00 PM

Eguana Announces First Large Order in California

This morning Eguana Technologies (TSXV: EGT) announced their first material purchase order from a California...

Monday, August 17, 2020, 11:54:15 AM

Eguana Tech: Stifel-GMP Raises Estimates, Lifts Price Target To $0.70

On May 30, Eguana Technologies (TSXV: EGT) announced its second-quarter financial results. The company reported...

Thursday, June 2, 2022, 02:11:00 PM

Eguana Tech Reports Q3 Revenues Of $2.3 Million, Highlights $27 Million Order Backlog

Eguana Technologies (TSXV: EGT) last night reported its third quarter financial results. The firm saw...

Tuesday, August 30, 2022, 08:26:29 AM